Featuresp19
Featuresp18
Newsp4-5
We speak to broadcaster Simon Singh about the need for libel law refom
Mental health: students' stories and the resources available to you
FRIDAY JANUARY 22ND 2010
A roundup of Cambridge's newest and most exciting literary magazines
THE INDEPENDENT STUDENT NEWSPAPER SINCE 1947
ISSUE NO 710 | VARSITY.CO.UK
Education Tripos gone by 2012
Stem cell findings will help treat MS JANE ASHFORD-THOM
Plans for a large-scale revamp of the undergraduate teaching of social sciences in Cambridge have been published. The General Board’s proposed changes would signal the end of the Education Tripos and see the creation of a new Social Sciences Tripos (SST). The shake-up is a means of “raising the profi le of Cambridge social sciences nationally and internationally,” according to a Review Committee Report published last Wednesday. Students may be enrolled in the new SST from October 2012. The degree would provide first year students with the opportunity to choose from sociology, politics and social and developmental psychology, as well as subjects currently covered in other Triposes, such as
law, criminology and geography. It is envisioned that around 160 students would take the new Tripos each year. The report stated that the proposed SST “has been almost universally welcomed” so far. However, many have expressed anger at the development. The drive to improve inter-disciplinary co-operation and to unify the social sciences began in January 2009 with the merging of the Faculty of Social and Political Science (SPS) and the Centre for International Studies (CIS) to form the Faculty of Politics, Psychology, Sociology and International Studies (PPSIS). Though the General Board denies the plans are motivated by fi nancial considerations, it admits, “As the need to reduce costs becomes ever more apparent, the fi nancial implications of the fragmented nature of social sciences at Cambridge need
to be considered.” The Committee acknowledges that “not all its recommendations will be universally welcomed” but “fi rmly believes that maintaining the status quo is not in the University’s best interests”. However, serious opposition has emerged to the proposed abolition of the education Tripos. The three-year undergraduate degree, currently taken by 150 students, will be withdrawn after the October 2011 intake, with the introduction of a one-year Part II taking effect from 2012-13. Speaking to Varsity, a senior member of the Faculty of Education said: “The Faculty does not support the withdrawal of the current education Tripos. The Cambridge education Tripos is rated as the best education degree in the country, highly commended by external examiners and by students. The Faculty of Education is committed
to providing opportunities for the most able students to study education in depth in a three-year degree.” The Committee also claimed that its decision to withdraw the education Tripos was partly due to the alleged poor quality of education students. According to the Committee, the education Tripos is “not presently cost-effective and attracts applicants whose A-level module scores do not match those in other subjects and who therefore do not necessarily rank as being of the highest calibre in a Cambridge context. “Undergraduate student applications, despite vigorous recruitment efforts by the Faculty, do not match its aspirations.” However, the senior member of the Faculty of Education refused to accept the report’s judgement, arguing that “the ultimate degree profi le of [our] CONTINUED ON PAGE 3
Essayp11 Alain de Botton: Why Cambridge disappoints
9 771758 444002
COLLEGE
CLAIRE GATZEN & JONNY WALKER
03 >
Planned changes to PPSIS curriculum could see Education Tripos scrapped
FARAZ DIANAT
Recent stem cell research by Cambridge professors has been hailed as a leap forward in providing future innovations in the treatment of multiple sclerosis. The £1 million research, funded by the UK Stem Cell Foundation and the Multiple Sclerosis Society, has proved groundbreaking in potentially offering drugs to stop or reverse nerve damage caused by the illness. The research is expected to provide drugs capable of renewing cells in the brain which regenerate myelin, a protective sheath around nerves which, when stripped away, interferes with the transmission of nerve messages around the body. The disease, which affects around 100,000 young people in the UK, causes symptoms ranging from fatigue to tremors and blindness. Professor Robin Franklin, a fellow of Pembroke College, commented that he is “pretty optimistic that in the not too distant future we'll have drugs that will promote regeneration by the brain's own stem cells.” The MS Society has called the research a “much needed shot in the arm”, in light of the “critical gap between currently available government and private funding and the countless promising research projects in need of fi nancial assistance”. Dr Doug Brown, the charity’s Biochemical Research Manager, hailed the move as a significant step forward.